<DOC>
	<DOCNO>NCT02978573</DOCNO>
	<brief_summary>Evaluate confirm long-term safety effectiveness Cartiva SCI implant establish pivotal trial .</brief_summary>
	<brief_title>Post Approval Study Evaluate Effectiveness Safety Cartiva Implant Treatment OA Great Toe</brief_title>
	<detailed_description>As part Conditions Approval Cartiva SCI treatment first MTP osteoarthritis , Food Drug Administration ( FDA ) require additional long term data evaluate long term safety effectiveness Cartiva include durability survivorship implant . This Post-Approval Study ( PAS ) addendum intend supplement initial 24 month follow period provide additional long term safety effectiveness data Cartiva</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Subject must treat Cartiva MOTION study protocol PTC0031 ; , Have inform nature study , agree requirement , sign informed consent approve IRB/Ethics Committee longterm followup . Subjects underwent secondary surgical intervention Cartiva implant remove 24month time period participation MOTION study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>First MTP Joint</keyword>
	<keyword>Hallux Rigidus</keyword>
	<keyword>Hallux Limitus</keyword>
	<keyword>Cartilage Replacement</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>First MTP Joint Osteoarthritis</keyword>
	<keyword>Big Toe Pain</keyword>
</DOC>